Blood vessels and neurons share guidance cues and cell-surface receptors to control their behaviour during embryogenesis. The transmembrane protein NRP1 (neuropilin 1) is present on both blood vessels and nerves and binds two structurally diverse ligands, the class 3 semaphorin SEMA3A and an isoform of the vascular endothelial growth factor VEGF-A termed VEGF 165 (VEGF 164 in mice). In vitro, SEMA3A competes with VEGF 164 for binding to NRP1 to modulate the migration of endothelial cells and neuronal progenitors. It was therefore hypothesized that NRP1 signalling controls neurovascular co-patterning by integrating competing VEGF 164 and SEMA3A signals. However, SEMA3A, but not VEGF 164 , is required for axon patterning of motor and sensory nerves, and, vice versa, VEGF 164 rather than SEMA3A is required for blood vessel development. Ligand competition for NRP1 therefore does not explain neurovascular congruence. Instead, these ligands control different aspects of neurovascular patterning that have an impact on cardiovascular function. Thus SEMA3A/NRP1 signalling guides the NCC (neural crest cell) precursors of sympathetic neurons as well as their axonal projections. In addition, VEGF 164 and a second class 3 semaphorin termed SEMA3C contribute to the remodelling of the embryonic pharyngeal arch arteries and primitive heart outflow tract by acting on endothelium and NCCs respectively. Consequently, loss of either of these NRP1 ligands disrupts blood flow into and out of the heart. Multiple NRP1 ligands therefore co-operate to orchestrate cardiovascular morphogenesis.
Introduction
Blood vessels and neurons share guidance cues and cell-surface receptors to control their behaviour during embryogenesis (reviewed in [1] ). For example, the transmembrane protein NRP (neuropilin) 1 is present on both blood vessels and nerves. NRP1 is a single-pass transmembrane protein that is specific to vertebrates. It has a large extracellular N-terminal domain that contains two complement-binding homology domains, known as a1 and a2, two coagulation factor V/VIII homology domains, known as b1 and b2, and a domain separating b2 from the transmembrane domain, termed c [2] . The a-and b-domains mediate ligand binding, the c-domain promotes dimerization and the interaction with other cell-surface receptors, and the intracellular domain binds a PDZ-domain-containing protein termed synectin or GIPC [GAIP (G α -interacting protein)-interacting protein C-terminus] ( Figure 1A ). Even though NRP1 was originally identified as an adhesion molecule in the nervous system, it is more commonly studied as a receptor for the semaphorin SEMA3A and the vascular endothelial growth factor (VEGF-A) isoform VEGF 165 (VEGF 164 in mice) [3] [4] [5] [6] . The closely related NRP2 protein Key words: blood vessel, neural crest, neuron, neuropilin, semaphorin, vascular endothelial growth factor (VEGF).
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was originally identified as a SEMA3F receptor, but has also been implicated in VEGF isoform binding and intercellular adhesion [7] [8] [9] . Both NRP1 and NRP2 recruit a member of the A-type plexin family to transduce semaphorin signals [10, 11] . In contrast, it is not yet clear whether NRP1 requires a co-receptor to transduce VEGF 164 signals, or whether signalling though its cytoplasmic domain is more important to promote VEGF signalling in vivo (see below).
Role of NRP1 ligands in neuronal development
SEMA3A was the first ligand reported to bind NRP1 and is well known for its ability to collapse the growth cones of NRP1-expressing axons in vitro [4, 5, 12] . In vivo, SEMA3A is essential to control fasciculation and branching of various types of nerves in the PNS (peripheral nervous system) and CNS (central nervous system) ( Figure 1A ) [13] . The defects of Sema3a-null mouse mutants are phenocopied in mice lacking NRP1 or carrying a mutation in the a1 domain of NRP1 that impairs binding to class 3 semaphorins [14, 15] . VEGF 164 also binds NRP1-expressing axon tracts [16] . However, loss of VEGF 164 does not compromise axon patterning in the PNS, as the cranial nerves and limb nerves appear normal in mice lacking VEGF 164 [16, 17] . In contrast, NRP1 can act as a VEGF-A receptor to control neuronal migration [17] . Thus the cell body migration of FBM (facial branchiomotor) neurons from their birthplace in the hindbrain to the site where they assemble into the paired facial motor nuclei requires VEGF 164 /NRP1 signalling, rather than semaphorins 165 -binding the b1/b2 domain; the b1/b2 domain also contains the adhesion domain, whose physiological function is not yet understood. The three last amino acid residues of the cytoplasmic domain mediate binding to the PDZ domain-containing protein GIPC1/synectin, which is important for vascular patterning in zebrafish. (B, C) NRP1 is essential for sympathetic chain assembly and sympathetic axon guidance. The SNS of wild-type (B) and Nrp1-null (C) mouse embryos at E (embryonic day) 12.5 was visualized by whole-mount immunohistochemistry for tyrosine hydroxylase. In wild-types, sympathetic neurons form a tight chain on each side of the dorsal aorta. In Nrp1-null mutants, most cell bodies are only loosely packed into chains, and there are many ectopic neurons, especially at limb level (the boxed area is shown in higher magnification in the inset of C). In addition, axons extend between the two chains, rather than running up and down each chain (arrowhead in C). (D, E) NRP1 is essential for proper brain vascularization. The subventricular vascular plexus of wild-type (D) and Nrp1-null (E) hindbrains at E11.5 was visualized by whole-mount fluorescent labelling for isolectin B4; only the right side of each flat-mounted hindbrain is shown. Note that the vessels in mutants are larger in diameter and form a sparse vascular network.
Isolectin B4 also labels brain macrophages, which appear as scattered single cells and are clearly visible in Nrp1-null mutants due to the paucity of blood vessels. Scale bars, 500 μm (B, C); 200 μm (D, E).
( Figure 1A ) [17] . Because Vegfa is expressed in cells along the migration path of FBM neurons, and VEGF 164 -coated beads attract them in hindbrain explants, VEGF 164 appears to provide a chemoattractive signal for these neurons.
Role of NRP1 ligands in blood vessel development
NRP1 is not only involved in neuronal patterning, but also essential for the formation of a functional vasculature during vertebrate development. Thus overexpression of NRP1 in the mouse embryo leads to increased vessel growth, and vessels are leaky and haemorrhagic, causing embryonic lethality [18] , and vice versa, the targeted disruption of NRP1 reduces vessel growth, in particular in the CNS [19] .
Since NRP1 was cloned as a VEGF 165 receptor in human endothelial and tumour cells [6] , much effort has been directed at identifying its precise role in vascular growth. Its contribution to VEGF-A signalling was first studied in cells derived from porcine aortic endothelium (PAE cells), because they lack expression of NRP1 and the main endothelial VEGF receptor, VEGFR2 [KDR (kinase insert domain-containing receptor)/FLK1 (fetal liver kinase 1)], and could therefore be engineered to selectively express either receptor alone or in combination. In this model, NRP1 increases the affinity of VEGF 165 for VEGFR2 to stimulate cell migration [6] . However, others have contested the idea that NRP1 increases the affinity of VEGF 165 for VEGFR2 and suggested that NRP1 instead increases VEGFR2 clustering and stability [20] . More recent work suggests that synectin/GIPC binds to the NRP1 cytoplasmic tail to promote ligand-dependent endocytosis of VEGFR2-NRP1 complexes [21] . Alternatively, or additionally, NRP1 may act on endothelium from a non-endothelial cell type in trans, as has been described for tumour cells [22] and haemopoietic cells [23] .
On the basis of the cell culture studies described above, and because the phenotype of tissue-specific knockout mice lacking NRP1 in vascular endothelium is similar to that of complete NRP1 knockouts, the essential role of NRP1 in vascular development is commonly attributed to its ability to act as a VEGF 164 receptor in endothelial cells [14] . However, we found that the vascular defects caused by loss of NRP1 are surprisingly different from those caused by loss of VEGF 164 . Thus NRP1 deficiency impairs neural tube vascularization more severely than loss of VEGF 164 , but it affects perisomitic vessel growth less severely [24, 25] . The loss of VEGF isoform signalling cannot therefore be entirely responsible for the vascular deficiency of Nrp1-null mutants, and it is likely that NRP1 ligands other than VEGF 164 contribute to vessel patterning.
SEMA3A has been proposed to act as an alternative NRP1 ligand in vascular growth. Thus VEGF 164 and SEMA3A were reported to compete for binding to NRP1 in PAE cells to modulate VEGF/VEGFR2-mediated endothelial cell migration [26] . However, recent biochemical data demonstrate that SEMA3A and VEGF 165 bind to distinct domains of NRP1 and can therefore bind simultaneously, rather than competitively [27] . SEMA3A has also been proposed to affect the migration of primary human umbilical cord endothelial cells by modulating integrin signalling [28] . Consistent with a role for SEMA3A in vessel patterning, it is able to bind blood vessels in the brain, the organ most severely affected by vascular defects in Nrp1-null mutants [16] . However, we and others have found that neither SEMA3A nor any form of semaphorin signalling through NRP1 appears to be essential for vascular development, and the combined loss of SEMA3A and VEGF 164 does not impair brain vascularization as severely as the loss of NRP1 [16] . Together, these observations suggest that NRP1 has a function in vascular development above and beyond its role as a VEGF 164 receptor that is not due to SEMA3A binding. Recently, NRP1 was shown to interact with a host of additional proteins, including several growth factors and adhesion molecules [29] [30] [31] [32] [33] . It will present a formidable challenge to vascular biologists to identify which of these interactions are physiologically relevant. We are particularly intrigued by the idea that NRPs interact with two types of adhesion molecule, L1-CAM (L1 cell adhesion molecule) and integrins, as it reminds us of the original discovery of NRP1 as an adhesion molecule.
Role of neuropilin ligands in the SNS (sympathetic nervous system)
Whereas semaphorin signalling through NRP1 is not essential for blood vessel growth, it does play an essential role in the cardiovasculature by patterning the SNS. Thus loss of SEMA3A leads to an insufficient supply of sympathetic innervation to the heart, causing heart arrhythmia and sudden death in adult mice [34] . These innervation defects can be attributed to an abnormal SNS development [35] . The SNS consists of two chains of ganglia that lie adjacent to the vertebral column and project axons to target organs, such as the heart and resistance arteries. Loss of function for either NRP1 or SEMA3A leads to ectopic sympathetic neuronal progenitors in the limb and abnormally small sympathetic chains [35] . These defects were originally attributed to a role for SEMA3A in guiding sympathetic neuronal progenitors [35] . However, our own investigations have revealed that SEMA3A and NRP1 are required at an even earlier stage of development, i.e. for the guidance of NCCs (neural crest cells) that are the precursors of sympathetic neuronal progenitors [36] .
NCCs are a population of highly migratory cells that exists transiently in the vertebrate body and gives rise to many different tissues (reviewed in [37] ). Within the nervous system, they form the entire SNS and PNS of the trunk and, together with placodal neurons, form the cranial ganglia. Within the cardiovasculature, they provide a smooth muscle coat for head vessels and the pharyngeal arch arteries.
Early in development, NCCs delaminate from the neural folds as they invaginate from the ectoderm to form the neural tube. NCCs then disseminate along distinct pathways, depending on their fate. Whereas NCCs destined for the heart delaminate at the level of the hindbrain, NCCs destined to become sympathetic neurons delaminate at trunk level. Sympathetic NCCs then travel towards the dorsal aorta, where they aggregate and differentiate into postmitotic sympathetic precursors. To reach the dorsal aorta, the sympathetic NCCs initially migrate ventrally between the somites, transient epithelial structures that are arranged segmentally along the anterior-posterior axis of the vertebrate trunk and later give rise to skin, muscle and bones. Following this route, the sympathetic NCCs migrate alongside intersomitic blood vessels, which extend between the dorsal aorta and the perineural vascular plexus. In contrast, later-born sympathetic NCCs migrate through the somites, concomitant with the segregation of the somite into a dermomyotome and sclerotome layer.
At first, it was thought that trunk NCC migration was unaffected by loss of NRP1 signalling in mice [35] . However, NRP1 has been implicated in NCC guidance in chick embryos [38] , and we found that a subset of cranial NCCs in the mouse require SEMA3A/NRP1 signalling to identify their appropriate migratory route [39] . We therefore reinvestigated the possibility that the defective sympathetic chain assembly in Nrp1-null mutants is due to a defect in trunk NCC guidance, using novel markers that are more specific to NCCs than those that had been employed previously [36] . We observed that an excess of NCCs migrated alongside intersomitic blood vessels in Sema3a-null and NCC-specific Nrp1-null mutant embryos, even though this route was taken by only a small subset of very early migrating NCCs in wild-type littermates. These displaced NCCs then aggregated distal to the dorsal aorta, explaining the position of the ectopic sympathetic ganglia observed previously. These findings provided the first evidence that SEMA3A/NRP1 signalling contributes to cardiovascular development by controlling the migration of NCCs. It is not yet known whether the alternative NRP1 ligand VEGF 164 also affects NCC migration, but there is evidence that VEGF-A affects the SNS to promote nerve regeneration [40] .
Role of NRP1 ligands in heart development
The finding that NRP1 signalling is important for CNS vascularization and the sympathetic innervation of heart and arteries demonstrate key roles in cardiovascular morphogenesis and function. However, the mid-gestation lethality of Nrp1-null mutants is more readily explained by defective remodelling of the heart OFT (outflow tract) and the pharyngeal arch arteries into the great vessels that leave the heart [19] . Importantly, these remodelling processes rely on the interaction of endothelial cells and a subset of NCCs, which are derived from the lower hindbrain and are commonly referred to as the cardiac NCCs (reviewed in [41] ).
After delamination from the lower hindbrain, cardiac NCCs migrate into the pharyngeal arches, where some come into close contact with the pharyngeal arch arteries and differentiate into vascular smooth muscle cells. The interaction between NCC-derived vascular smooth muscle and endothelial cells promotes the remodelling of the pharyngeal arch arteries. Defects in this process can lead to an overriding aorta and a hypoplastic pulmonary trunk in a condition known as Tetralogy of Fallot. Other cardiac NCCs continue to migrate to invade the primitive cardiac OFT, where they induce the formation of a septum that separates the OFT into aorta and pulmonary artery. Defects in this process lead to a lethal condition known as persistent truncus arteriosus, in which arterial and venous blood mixes as it leaves the heart. Both defects can occur together with craniofacial, thymic and parathyroid abnormalities in a relatively common congenital disease known as DiGeorge syndrome. The functional analysis of genetic mutations that affect OFT and aortic arch remodelling is complex and not yet complete because cardiac NCCs interact with multiple cell types during heart development, including pharyngeal arch epithelium and mesenchyme as well as the vascular endothelium that lines the aortic arch arteries and OFT [41] .
Genetic studies have implicated both semaphorin and VEGF ligands for NRP1 in the remodelling of the great vessels. Thus loss of VEGF 164 inhibits OFT remodelling in mice. Moreover, VEGF 164 interacts genetically with the gene encoding TBX1 (T-box 1) [42] , and TBX1 gene function is compromised in many patients with DiGeorge syndrome (reviewed in [41] ). Finally, a specific VEGFA promoter haplotype is associated with an increased risk of cardiovascular complications in patients with DiGeorge syndrome [42] . The deletion of NRP1 in vascular endothelium also leads to defective OFT septation [14] , suggesting that VEGF 164 /NRP1 signalling is more important in endothelial cells than in cardiac NCCs for this process.
In contrast, loss of SEMA3A has not been reported to cause OFT defects. Rather, an alternative NRP ligand termed SEMA3C is essential for OFT septation [43] . SEMA3C is likely to signal through an NRP in complex with PLXND1 (plexin D1) in endothelial cells of the OFT [44] , because loss of PLXND1 results in similar OFT defects to loss of SEMA3C [44] . In contrast, ablating semaphorin signalling through both neuropilins is necessary to reproduce the OFT defect of Sema3c-null mutants [14] , presumably because SEMA3C can bind NRP2 or NRP1 [45] .
NRP1 is also expressed in cardiac NCCs as they migrate within the pharyngeal arches [46] . Consistent with the idea that NRP1 plays a role in aortic arch smooth muscle development, loss of NRP1 in mice leads to agenesis or transposition of the remodelling aortic arch arteries [19] . It is not yet known whether these defects are due to endothelial cells failing to recruit cardiac NCC-derived cells that form smooth muscle cells or whether cardiac NCCs are recruited, but fail to differentiate into proper smooth muscle cells on the arch arteries. PLXND1 is required for smooth muscle cell differentiation on the fourth and sixth pharyngeal arch arteries, probably because it forms a receptor complex with NRP1 or NRP2 to mediate SEMA3C signals, as in OFT development [44] . However, the absence of VEGF 164 also perturbs aortic arch remodelling [42] , raising the possibility that NRP1 plays a dual role in pharyngeal arch development as a VEGF and semaphorin receptor.
Conclusions
NRP1 plays multiple roles in neuronal and vascular development by interacting with a variety of different ligands and co-receptors, and several of these pathways are critical for cardiovascular morphogenesis and function. Even though the combination of in vitro assays, expression studies and genetic models performed by a large number of different laboratories has helped to elucidate the significance of semaphorin and VEGF binding to NRP1, much remains to be learnt about the physiological role of the adhesion ligands and GIPC/synectin in neurovascular development. 
